CLINICAL TRIAL OF HEMATOPOIETIC STEM CELL GENE THERAPY FOR WISKOTT-ALDRICH-SYNDROME
- 8 Anni 2010/2018
 - 4.079.127€ Totale Fondi
 
Descrizione non disponibile
Pubblicazioni Scientifiche
- 2016 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 
A novel genomic inversion in Wiskott-Aldrich–associated autoinflammation
 - 2011 Blood 
T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression
 - 2014 CURRENT GENE THERAPY 
Gene Therapy for Wiskott-Aldrich Syndrome